Latest Insider Transactions at Haemonetics Corp (HAE)
This section provides a real-time view of insider transactions for Haemonetics Corp (HAE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HAEMONETICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HAEMONETICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 07
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
411
-1.17%
|
$22,605
$55.09 P/Share
|
Jun 07
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
442
-1.13%
|
$24,310
$55.09 P/Share
|
Jun 07
2021
|
Jacqueline Scanlan SVP, Global Human Resources |
SELL
Open market or private sale
|
Direct |
195
-4.42%
|
$10,725
$55.09 P/Share
|
Jun 07
2021
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
81
-1.94%
|
$4,455
$55.09 P/Share
|
Jun 01
2021
|
Dan Goldstein VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,753
+29.58%
|
-
|
May 26
2021
|
Mark W Kroll Director |
SELL
Open market or private sale
|
Direct |
11,813
-39.05%
|
$649,715
$55.1 P/Share
|
May 26
2021
|
Mark W Kroll Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,353
+25.5%
|
$362,355
$35.5 P/Share
|
May 19
2021
|
Jacqueline Scanlan SVP, Global Human Resources |
SELL
Open market or private sale
|
Direct |
112
-2.48%
|
$6,160
$55.19 P/Share
|
May 19
2021
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
1,024
-0.52%
|
$56,320
$55.19 P/Share
|
May 19
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
238
-0.67%
|
$13,090
$55.19 P/Share
|
May 19
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
220
-0.56%
|
$12,100
$55.19 P/Share
|
May 19
2021
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
125
-0.85%
|
$6,875
$55.19 P/Share
|
May 19
2021
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
92
-0.64%
|
$5,060
$55.19 P/Share
|
May 19
2021
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
42
-1.71%
|
$2,310
$55.19 P/Share
|
May 18
2021
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,515
+11.88%
|
-
|
May 18
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,305
+30.24%
|
-
|
May 18
2021
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
23,864
+26.66%
|
-
|
May 18
2021
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
10,605
+31.97%
|
-
|
May 18
2021
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,605
+32.97%
|
-
|
May 18
2021
|
Dan Goldstein VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
994
+28.75%
|
-
|
May 17
2021
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
956
-0.56%
|
$52,580
$55.97 P/Share
|
May 17
2021
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
219
-1.93%
|
$12,045
$55.97 P/Share
|
May 17
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
204
-1.31%
|
$11,220
$55.97 P/Share
|
May 17
2021
|
Jacqueline Scanlan SVP, Global Human Resources |
SELL
Open market or private sale
|
Direct |
102
-2.21%
|
$5,610
$55.97 P/Share
|
May 17
2021
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
114
-2.68%
|
$6,270
$55.97 P/Share
|
May 17
2021
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
42
-2.78%
|
$2,310
$55.97 P/Share
|
Apr 16
2021
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
170
-4.7%
|
$20,230
$119.44 P/Share
|
Mar 08
2021
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
385
-2.41%
|
$46,200
$120.07 P/Share
|
Mar 08
2021
|
Jacqueline Scanlan SVP, Global Human Resources |
SELL
Open market or private sale
|
Direct |
107
-2.38%
|
$12,840
$120.07 P/Share
|
Feb 04
2021
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
2,671
-25.67%
|
$360,585
$135.92 P/Share
|
Feb 04
2021
|
Dan Goldstein VP, Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,433
+22.35%
|
$182,475
$75.25 P/Share
|
Feb 04
2021
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
12,180
-46.96%
|
$1,632,120
$134.53 P/Share
|
Feb 04
2021
|
Charles J Dockendorff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,180
+31.96%
|
$426,300
$35.5 P/Share
|
Feb 04
2021
|
Richard J Meelia Director |
SELL
Open market or private sale
|
Direct |
10,353
-24.42%
|
$1,387,302
$134.64 P/Share
|
Feb 04
2021
|
Richard J Meelia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,353
+19.62%
|
$362,355
$35.5 P/Share
|
Dec 10
2020
|
Simon, Christopher President & CEO |
SELL
Bona fide gift
|
Direct |
194,369
-53.21%
|
-
|
Oct 26
2020
|
William P. Burke Mr. EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,161
-9.29%
|
$123,066
$106.0 P/Share
|
Oct 26
2020
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
100
-5.41%
|
$10,600
$106.0 P/Share
|
Oct 23
2020
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
181
-1.12%
|
$19,186
$106.58 P/Share
|